Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer

Molecular and Cellular Proteomics

Volumn 4, Issue 11, 2005, Pages 1686-1696

  Zhang, DaoHai ^a   Tai, Lee Kian ^b   Wong, Lee Lee ^b   Chiu, Lily Lily ^a   Sethi, Sunil K ^a,b   Koay, Evelyn S C ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FATTY ACID SYNTHASE; GLYOXALASE; HAPTOGLOBIN; HEAT SHOCK PROTEIN 27; OXIDOREDUCTASE; PHOSPHOGLYCERATE KINASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; TRASTUZUMAB; TRIOSEPHOSPHATE ISOMERASE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL CYCLE; CELL PROLIFERATION; CORRELATION ANALYSIS; DETOXIFICATION; ENZYME ACTIVITY; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LIPID METABOLISM; LIPOGENESIS; LYMPH NODE METASTASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS POTENTIAL; MICROENVIRONMENT; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SIGNAL TRANSDUCTION; TARGET CELL; TISSUE MICROARRAY; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; VALIDATION PROCESS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LACTOYLGLUTATHIONE LYASE; METABOLIC DETOXICATION, DRUG; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PHOSPHOGLYCERATE KINASE; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 28644439593     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M400221-MCP200     Document Type: Article

References (44)

1. Yarden, Y., and Sliwkowski, M. X. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2, 127-137
2. Isola, J., Chu, L., DeVries, S., Matsumura, K., Chew, K., Ljung, B. M., and Waldman, F. M. (1999) Genetic alterations in ERBB2-amplified breast carcinomas. Clin. Cancer Res. 5, 4140-4145
3. Zhang, D.-H., Salto-Tellez, M., Do, E., Putti, T. C., and Koay, E. S. C. (2003) Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays. Hum. Pathol. 34, 362-368
4. Citri, A., Skaria, K. B., and Yarden, Y. (2003) The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp. Cell Res. 284, 54-65
5. Pietras, R. J., Arboleda, J., Reese, D. M., Wongvipat, N., Pegram, M. D., Ramos, L., Gorman, C. M., Parker, M. G., Sliwkowski, M. X., and Slmon, D. J. (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10, 2435-2446
6. Alaoui-Jamali, M. A., Paterson, J., Al Moustafa, A.-E., and Yen, L. (1997) The role of ErbB2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications. Biochem. Cell Biol. 75, 315-325
7. Wilson, K. S., Roberts, H., Leek, R., Harris, A. L., and Geradts, J. (2002) Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues. Am. J. Pathol. 161, 1171-1185
8. Mackay, A., Jones, C., Dexter, T., Silva, R. L., Bulmer, K., Jones, A., Simpson, P., Harris, R. A., Jat, P. S., Neville, A. M., Reis, L. F., Lakhani, S., and O'Hare, M. J. (2003) cDNA microarray analysis of genes associated with ErbB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene 22, 2680-2688
9. White, S. L., Gharbi, S., Bertani, M. F., Chan, H.-L., Waterfield, M. D., and Timms, J. F. (2004) Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression. Br. J. Cancer 90, 173-181
10. Kumar-Sinha, C., Ignatoski, K. W., Lippman, M. E., Ethier, S. P., and Chinnaiyan, A. M. (2003) Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res. 63, 132-139
11. Menendez, J. A., Vellon, L., Mehmi, I., Oza, B. P., Ropero, S., Colomer, R., and Lupu, R. (2004) Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc. Natl. Acad. Sci. U. S. A. 101, 10715-10720
12. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., and Semenza, G. L. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor-1α (HIF-1 α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995-4004
13. Hernan, R., Fasheh, R., Calabrese, C., Frank, A. J., Maclean, K. H., Allard, D., Barraclough, R., and Gilbertson, R. J. (2003) ErbB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res. 63, 140-148
14. Adam, L., Vadlamudi, R., Kondapaka, S. B., Chernoff, J., Mendelsohn, J., and Kumar, R. (1998) Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol 3-kinase. J. Biol. Chem. 273, 28238-28246
15. Zhang, Y., Yang, H.-Y., Zhang, X.-C., Yang, H., Tsai, M., and Lee, M.-H. (2004) Tumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growth. Oncogene 23, 7132-7143
16. Chen, J., He, Q.-Y., Yuen, A. P.-W., and Chiu, J.-F. (2004) Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 4, 2465-2475
17. Tomonaga, T., Matsushita, K., Yamaguchi, S., Oh-Ishi, M., Kodera, Y., Maeda, T., Shimada, H., Ochiai, T., and Nomura, F. (2004) Identification of altered protein expression and post-translational modification in primary colorectal cancer by using agarose two-dimensional gel electrophoresis. Clin. Cancer Res. 10, 2007-2014
18. Ahmed, N., Barker, G., Oliva, K. T., Hoffmann, P., Riley, C., Reeve, S., Smith, A. I., Kemp, B. E., Quinn, M. A., and Rice, G. E. (2004) Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br. J. Cancer 91, 129-140
19. Juan, H.-F., Chen, J.-H., Hsu, W.-T., Huang, S.-C., Chen, S.-T., Lin, J. Y.-C., Chang, Y.-W., Chiang, C.-Y., Wen, L.-L., Chan, D.-C., Liu, Y.-C., and Chen, Y.-J. (2004) Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human. Proteomics 4, 2766-2775
20. Gharbi, S., Gaffney, P., Yang, A., Zvelebil, M. J., Cramer, R., Waterfield, M. D., and Timms, J. F. (2002) Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell. Proteomics 1, 91-98
21. Zhang, D.-H., Tai, L. K., Wong, L. L., Sethi, S. K., and Koay, E. S. C. (2005) Proteomics of breast cancer: enhanced expression of cytokeratin19 in HER-2/neu-positive breast tumors. Proteomics 5, 1797-1805
22. Zhang, D.-H., Salto-Tellez, M., Putti, T. C., Do, E., and Koay, E. S. C. (2003) Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod. Pathol. 16, 79-84
23. Love, S., and King, R. J. (1994) A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br. J. Cancer 69, 743-749
24. Vargas-Roig, L. M., Gago, F. E., Tello, O., Aznar, J. C., and Ciocca, D. R. (1998) Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int. J. Cancer 79, 468-475
25. Swinnen, J. V., Roskams, T., Joniau, S., Van Poppel, H., Oyen, R., Baert, L., Heyns, W., and Verhoeven, G. (2002) Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int. J. Cancer 98, 19-22
26. Milgraum, L. Z., Witters, L. A., Pasternack, G. R., and Kuhajda, F. P. (1997) Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin. Cancer Res. 3, 2115-2120
27. Deleted in proof
28. Deleted in proof
29. Menendez, J. A., Mehmi, I., Verma, V. A., Teng, P. K., and Lupu, R. (2004) Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Mol. Carcinog. 41, 164-178
30. Concannon, C. G., Gorman, A. M., and Samali, A. (2003) On the role of Hsp27 in regulating apoptosis. Apoptosis 8, 61-70
31. Chen, J., Kahne, T., Rocken, C., Gotze, T., Yu, J., Sung, J. J., Chen, M., Hu, P., Malfertheiner, P., and Ebert, M. P. (2004) Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ ionization-mass spectrometry for identification of metastasis-related proteins. J. Proteome Res. 3, 1009-1016
32. Santo, C., Valsecchi, C., Magni, F., Tremolada, L., Arizzi, C., Cordani, N., Casellato, S., Doro, G., Favini, P., Perego, R. A., Raimondo, F., Ferrero, S., Mocarelli, P., and Galli-Kienle, M. (2004) Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics 4, 2252-2260
33. Rocchi, P., So, A., Kojima, S., Signaevsky, M., Beraldi, E., Fazli, L., Hurtado-Coll, A., Yamanaka, K., and Gleave, M. (2004) Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res. 64, 6595-6602
34. Paul, C., Manero, F., Gonin, S., Kretz-Remy, C., Virot, S., and Arrigo, A.-P. (2002) Hsp27 as a negative regulator of cytochrome c release. Mol. Cell. Biol. 22, 816-834
35. Lay, A. J., Jiang, X. M., Kisker, O., Flynn, E., Underwood, A., Condron, R., and Hogg, P. J. (2000) Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase. Nature 408, 869-873
36. Kress, S., Stein, A., Maurer, P., Weber, B., Reichert, J., Buchmann, A., Huppert, P., and Schwarz, M. (1998) Expression of hypoxia-inducible genes in tumor cells. J. Cancer Res. Clin. Oncol. 124, 315-320
37. Popanda, O., Fox, G., and Thielmann, H. W. (1998) Modulation of DNA polymerase α, δ and ε by lactate dehydrogenase and 3-phosphoglycerate kinase. Biochim. Biophys. Acta 1397, 102-117
38. Duan, Z., Lamendola, D. E., Yusuf, R. Z., Penson, R. T., Preffer, F. I., and Seiden, M. V. (2002) Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype. Anticancer Res. 22, 1933-1941
39. Unwin, R. D., Craven, R. A., Harnden, P., Hanrahan, S., Totty, N., Knowles, M., Eardley, I., Selby, P. J., and Banks, R. E. (2003) Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 3, 1620-1632
40. Shichijo, S., Azuma, K., Komatsu, N., Ito, M., Maeda, Y., Ishihara, Y., and Itoh, K. (2004) Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic I lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer. Clin. Cancer Res. 10, 5828-5836
41. Sakamoto, H., Mashima, T., Kizaki, A., Dan, S., Hashimoto, Y., Naito, M., and Tsuruo, T. (2000) Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 95, 3214-3218
42. Sakamoto, H., Mashima, T., Sato, S., Hashimoto, Y., Yamori, T., and Tsuruo, T. (2001) Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells. Clin. Cancer Res. 7, 2513-2518
43. Chen, F., Wollmer, M. A., Hoerndli, F., Munch, G., Kuhla, B., Rogaev, E. I., Tsolaki, M., Papassotiropoulos, A., and Gotz, J. (2004) Role for glyoxalase I in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 101, 7687-7692
44. Tsuruo, T., Naito, M., Tomida, A., Fujita, N., Mashima, T., Sakamoto, H., and Haga, N. (2003) Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci. 94, 15-21